The pluripotency factor NANOG promotes the formation of squamous cell carcinomas

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Palla, Adelaida R ^a   Piazzolla, Daniela ^a   Alcazar, Noelia ^a   Cañamero, Marta ^a   Graña, Osvaldo ^a   Gómez López, Gonzalo ^a   Dominguez, Orlando ^a   Dueñas, Marta ^b,c   Paramio, Jesús M ^b,c   Serrano, Manuel ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

^b CIEMAT   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; NANOG PROTEIN, MOUSE; TRANSCRIPTION FACTOR NANOG;

ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CANCER STEM CELL; CELL PROLIFERATION; CELL TRANSFORMATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KERATINOCYTE; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PAPILLOMA; PATHOLOGY; PROMOTER REGION; SEQUENCE ANALYSIS; SKIN; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TRANSFORMED CELL LINE; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; KERATINOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NANOG HOMEOBOX PROTEIN; NEOPLASTIC STEM CELLS; PAPILLOMA; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, RNA; SKIN; SKIN NEOPLASMS;

EID: 84930194192     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10205     Document Type: Article

References (55)

1. Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655 (2003).
2. Mitsui, K. et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642 (2003).
3. Wang, J. et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 444, 364-368 (2006).
4. Suva, M. L., Riggi, N. & Bernstein, B. E. Epigenetic reprogramming in cancer. Science 339, 1567-1570 (2013).
5. Boumahdi, S. et al. SOX2 controls tumour initiation and cancer stem cell functions in squamous cell carcinoma. Nature 511, 246-250 (2014).
6. Bass, A. J. et al. SOX2 is an amplifed lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat. Genet. 41, 1238-1242 (2009).
7. Liu, K. et al. Sox2 cooperates with infammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem. Cell 12, 304-315 (2013).
8. Rudin, C. M. et al. Comprehensive genomic analysis identifes SOX2 as a frequently amplifed gene in small-cell lung cancer. Nat. Genet. 44, 1111-1116 (2012).
9. Santaliz-Ruiz, L. E. et al. Emerging role of nanog in tumorigenesis and cancer stem cells. Int. J. Cancer (2013) 135, 2741-2748.
10. Wang, M. L., Chiou, S. H. & Wu, C. W. Targeting cancer stem cells: emerging role of Nanog transcription factor. Onco Targets T e r. 6, 1207-1220 (2013).
11. Lu, X., Mazur, S. J., Lin, T., Appella, E. & Xu, Y. The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. Oncogene 33, 2655-2664 (2014).
12. Chiou, S. H. et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 14, 4085-4095 (2008).
13. Bourguignon, L. Y., Earle, C., Wong, G., Spevak, C. C. & Krueger, K. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene 31, 149-160 (2012).
14. Bourguignon, L. Y., Wong, G., Earle, C. & Chen, L. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J. Biol. Chem. 287, 32800-32824 (2012).
15. Watanabe, M. et al. NANOG expression correlates with diferentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma. Oncol. Lett. 7, 35-40 (2014).
16. Piazzolla, D. et al. Lineage-restricted function of the pluripotency factor NANOG in stratifed epithelia. Nat. Commun. 5, 4226 (2014).
17. Hochedlinger, K., Yamada, Y., Beard, C. & Jaenisch, R. Ectopic expression of Oct-4 blocks progenitor-cell diferentiation and causes dysplasia in epithelial tissues. Cell 121, 465-477 (2005).
18. Vitale-Cross, L., Amornphimoltham, P., Fisher, G., Molinolo, A. A. & Gutkind, J. S. Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufcient to promote squamous cell carcinogenesis. Cancer Res. 64, 8804-8807 (2004).
19. Fuchs, E. Finding one's niche in the skin. Cell Stem Cell 4, 499-502 (2009).
20. Xie, X. et al. Phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis. Oncogene 33, 2040-2052 (2014).
21. Abel, E. L., Angel, J. M., Kiguchi, K. & DiGiovanni, J. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat. Protoc. 4, 1350-1362 (2009).
22. Hennings, H. et al. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14, 2353-2358 (1993).
23. Blick, T. et al. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J. Mammary Gland Biol. Neoplasia 15, 235-252 (2010).
24. Jechlinger, M. et al. Expression profling of epithelial plasticity in tumor progression. Oncogene 22, 7155-7169 (2003).
25. Taube, J. H. et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl. Acad. Sci. USA 107, 15449-15454 (2010).
26. Bornachea, O. et al. EMT and induction of miR-21 mediate metastasis development in Trp53-defcient tumours. Sci. Rep. 2, 434 (2012).
27. Garzon, R., Marcucci, G. & Croce, C. M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug. Discov. 9, 775-789 (2010).
28. Ma, X. et al. Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc. Natl. Acad. Sci. USA 108, 10144-10149 (2011).
29. Medina, P. P., Nolde, M. & Slack, F. J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86-90 (2010).
30. Hatley, M. E. et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18, 282-293 (2010).
31. Gupta, P. B. et al. Identifcation of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138, 645-659 (2009).
32. Rosenbloom, K. R. et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res. 41, D56-63 (2013).
33. Nieto, M. A. & Cano, A. The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin. Cancer Biol. 22, 361-368 (2012).
34. Chiou, S. H. et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdiferentiation. Cancer Res. 70, 10433-10444 (2010).
35. Sun, C. et al. NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway. Int. J. Biochem. Cell Biol. 45, 1099-1108 (2013).
36. Nieto, M. A. Epithelial plasticity: a common theme in embryonic and cancer cells. Science 342, 1234850 (2013).
37. Kumarswamy, R., Volkmann, I. & Tum, T. Regulation and function of miRNA-21 in health and disease. RNA Biol. 8, 706-713 (2011).
38. Teicher, B. A. & Fricker, S. P. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin. Cancer Res. 16, 2927-2931 (2010).
39. Leushacke, M. & Barker, N. Lgr5 and Lgr6 as markers to study adult stem cell roles in self-renewal and cancer. Oncogene 31, 3009-3022 (2012).
40. Tam, W. L. et al. Protein kinase C alpha is a central signaling node and therapeutic target for breast cancer stem cells. Cancer Cell 24, 347-364 (2013).
41. Okano, J., Gaslightwala, I., Birnbaum, M. J., Rustgi, A. K. & Nakagawa, H. Akt/protein kinase B isoforms are diferentially regulated by epidermal growth factor stimulation. J. Biol. Chem. 275, 30934-30942 (2000).
42. Burns, P. A. et al. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecifc hybrid mice. Oncogene 6, 2363-2369 (1991).
43. Yuspa, S. H., Hawley-Nelson, P., Koehler, B. & Stanley, J. R. A survey of transformation markers in diferentiating epidermal cell lines in culture. Cancer Res. 40, 4694-4703 (1980).
44. Buchmann, A., Ruggeri, B., Klein-Szanto, A. J. & Balmain, A. Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res. 51, 4097-4101 (1991).
45. Quintanilla, M. et al. Comparison of ras activation during epidermal carcinogenesis in vitro and in vivo. Carcinogenesis 12, 1875-1881 (1991).
46. Yuspa, S. H. et al. Cultivation and characterization of cells derived from mouse skin papillomas induced by an initiationpromotion protocol. Carcinogenesis 7, 949-958 (1986).
47. Trapnell, C. et al. Diferential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufinks. Nat. Protoc. 7, 562-578 (2012).
48. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efcient alignment of short DNA sequences to the human genome. Genome. Biol. 10, R25 (2009).
49. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
50. Karolchik, D. et al. The UCSC Genome Browser database: 2014 update. Nucleic Acids Res. 42, D764-770 (2014).
51. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profles. Proc. Natl. Acad Sci. USA 102, 15545-15550 (2005).
52. Yuan, J. S., Reed, A., Chen, F. & Stewart, C. N., Jr. Statistical analysis of real-time PCR data. BMC Bioinformatics 7, 85 (2006).
53. Giford, C. A. et al. Transcriptional and epigenetic dynamics during specifcation of human embryonic stem cells. Cell 153, 1149-1163 (2013).
54. Lee, D. F. et al. Combining competition assays with genetic complementation strategies to dissect mouse embryonic stem cell self-renewal and pluripotency. Nat. Protoc. 7, 729-748 (2012).
55. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).